Viatris Basic EPS 2010-2025 | VTRS

Viatris annual/quarterly basic eps history and growth rate from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
  • Viatris basic eps for the quarter ending March 31, 2025 was $-2.55, a 2650% decline year-over-year.
  • Viatris basic eps for the twelve months ending March 31, 2025 was $-3.18, a 7850% increase year-over-year.
  • Viatris annual basic eps for 2024 was $-0.001B, a 1160% decline from 2023.
  • Viatris annual basic eps for 2023 was $0B, a 97.08% decline from 2022.
  • Viatris annual basic eps for 2022 was $0.002B, a 262.86% decline from 2021.
Viatris Annual Basic EPS
2024 $-0.53
2023 $0.05
2022 $1.71
2021 $-1.05
2020 $-1.11
2019 $0.03
2018 $0.69
2017 $1.30
2016 $0.94
2015 $1.80
2014 $2.49
2013 $1.63
2012 $1.54
2011 $1.25
2010 $0.69
2009 $0.31
Viatris Quarterly Basic EPS
2025-03-31 $-2.55
2024-12-31 $-0.44
2024-09-30 $0.08
2024-06-30 $-0.27
2024-03-31 $0.10
2023-12-31 $-0.64
2023-09-30 $0.28
2023-06-30 $0.22
2023-03-31 $0.19
2022-12-31 $0.83
2022-09-30 $0.29
2022-06-30 $0.26
2022-03-31 $0.33
2021-12-31 $-0.22
2021-09-30 $0.26
2021-06-30 $-0.23
2021-03-31 $-0.86
2020-12-31 $-1.59
2020-09-30 $0.36
2020-06-30 $0.08
2020-03-31 $0.04
2019-12-31 $0.04
2019-09-30 $0.37
2019-06-30 $-0.33
2019-03-31 $-0.05
2018-12-31 $0.11
2018-09-30 $0.34
2018-06-30 $0.07
2018-03-31 $0.17
2017-12-31 $0.45
2017-09-30 $0.17
2017-06-30 $0.56
2017-03-31 $0.12
2016-12-31 $0.81
2016-09-30 $-0.23
2016-06-30 $0.33
2016-03-31 $0.03
2015-12-31 $0.45
2015-09-30 $0.87
2015-06-30 $0.34
2015-03-31 $0.14
2014-12-31 $0.51
2014-09-30 $1.33
2014-06-30 $0.34
2014-03-31 $0.31
2013-12-31 $0.47
2013-09-30 $0.42
2013-06-30 $0.47
2013-03-31 $0.27
2012-12-31 $0.39
2012-09-30 $0.52
2012-06-30 $0.33
2012-03-31 $0.30
2011-12-31 $0.30
2011-09-30 $0.37
2011-06-30 $0.34
2011-03-31 $0.24
2010-12-31 $-0.03
2010-09-30 $0.35
2010-06-30 $0.17
2010-03-31 $0.20
2009-12-31 $0.02
2009-09-30 $-0.13
2009-06-30 $0.19
2009-03-31 $0.23
Sector Industry Market Cap Revenue
Medical Medical Services $10.340B $14.739B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.561B 26.74
Elevance Health (ELV) United States $88.026B 11.36
CVS Health (CVS) United States $80.784B 10.04
Cencora (COR) United States $55.036B 19.15
DiDi Global (DIDIY) China $23.580B 35.79
Natera (NTRA) United States $22.420B 0.00
BioMerieux (BMXMF) France $16.097B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.007B 0.00
Solventum (SOLV) United States $12.962B 13.72
CochLear (CHEOY) Australia $11.342B 0.00
ICON (ICLR) Ireland $11.283B 10.49
Revvity (RVTY) United States $10.948B 18.84
Doximity (DOCS) United States $10.905B 50.49
HealthEquity (HQY) United States $9.613B 42.11
Avantor (AVTR) United States $9.165B 13.32
Medpace Holdings (MEDP) United States $8.574B 22.77
Sonic Healthcare (SKHHY) Australia $8.388B 0.00
Charles River Laboratories (CRL) United States $7.243B 14.19
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.238B 24.96
BrightSpring Health Services (BTSG) United States $4.157B 38.48
Sotera Health (SHC) United States $3.508B 19.93
Surgery Partners (SGRY) United States $2.994B 38.93
Alignment Healthcare (ALHC) United States $2.924B 0.00
Concentras Parent (CON) United States $2.830B 16.36
Organon (OGN) United States $2.537B 2.70
GeneDx Holdings (WGS) United States $2.066B 79.58
Ardent Health Partners (ARDT) United States $1.957B 8.34
Premier (PINC) United States $1.900B 14.43
Progyny (PGNY) United States $1.883B 41.45
PACS (PACS) United States $1.586B 0.00
GoodRx Holdings (GDRX) United States $1.468B 29.36
Teladoc Health (TDOC) United States $1.298B 0.00
Pediatrix Medical (MD) United States $1.214B 9.24
Establishment Labs Holdings (ESTA) $1.113B 0.00
CareDx (CDNA) United States $1.098B 17.15
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.944B 0.00
AMN Healthcare Services Inc (AMN) United States $0.818B 7.66
QDM (QDMI) Hong Kong, SAR China $0.752B 0.00
Nutex Health (NUTX) United States $0.654B 9.90
Embecta (EMBC) United States $0.579B 3.90
LifeMD (LFMD) United States $0.566B 0.00
Enhabit (EHAB) United States $0.546B 44.92
InnovAge Holding (INNV) United States $0.520B 0.00
SBC Medicals (SBC) United States $0.507B 0.00
Sonida Senior Living (SNDA) United States $0.472B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.60
COMPASS Pathways (CMPS) United Kingdom $0.437B 0.00
Performant Healthcare (PHLT) United States $0.244B 0.00
Oncology Institute (TOI) United States $0.232B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
DocGo (DCGO) United States $0.163B 26.67
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.099B 0.00
So-Young (SY) China $0.091B 0.00
Basel Medical Group (BMGL) Singapore $0.081B 0.00
KindlyMD (NAKA) United States $0.081B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Sera Prognostics (SERA) United States $0.057B 0.00
ModivCare (MODV) United States $0.050B 0.00
Biodesix (BDSX) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00